Literature DB >> 14988166

Aspirin resistance.

Graeme J Hankey, John W Eikelboom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14988166      PMCID： PMC351832          DOI： 10.1136/bmj.328.7438.477

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  C-reactive protein--to screen or not to screen?

Authors:  Lori Mosca
Journal:  N Engl J Med       Date:  2002-11-14       Impact factor: 91.245

Review 2.  Scientific and therapeutic advances in antiplatelet therapy.

Authors:  Deepak L Bhatt; Eric J Topol
Journal:  Nat Rev Drug Discov       Date:  2003-01       Impact factor: 84.694

Review 3.  Aspirin resistance: definition, mechanisms and clinical read-outs.

Authors:  C Patrono
Journal:  J Thromb Haemost       Date:  2003-08       Impact factor: 5.824

4.  Aspirin resistance: a revival of platelet aggregation tests?

Authors:  G De Gaetano; C Cerletti
Journal:  J Thromb Haemost       Date:  2003-09       Impact factor: 5.824

5.  Profile and prevalence of aspirin resistance in patients with cardiovascular disease.

Authors:  P A Gum; K Kottke-Marchant; E D Poggio; H Gurm; P A Welsh; L Brooks; S K Sapp; E J Topol
Journal:  Am J Cardiol       Date:  2001-08-01       Impact factor: 2.778

6.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Authors: 
Journal:  BMJ       Date:  2002-01-12

7.  Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events.

Authors:  John W Eikelboom; Jack Hirsh; Jeffrey I Weitz; Marilyn Johnston; Qilong Yi; Salim Yusuf
Journal:  Circulation       Date:  2002-04-09       Impact factor: 29.690

8.  Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs.

Authors:  Tobias Kurth; Robert J Glynn; Alexander M Walker; K Arnold Chan; Julie E Buring; Charles H Hennekens; J Michael Gaziano
Journal:  Circulation       Date:  2003-08-25       Impact factor: 29.690

9.  Development of aspirin resistance in persons with previous ischemic stroke.

Authors:  C M Helgason; K M Bolin; J A Hoff; S R Winkler; A Mangat; K L Tortorice; L D Brace
Journal:  Stroke       Date:  1994-12       Impact factor: 7.914

10.  A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease.

Authors:  Patricia A Gum; Kandice Kottke-Marchant; Patricia A Welsh; Jennifer White; Eric J Topol
Journal:  J Am Coll Cardiol       Date:  2003-03-19       Impact factor: 24.094
View more
  14 in total

Review 1.  Old and new molecular mechanisms associated with platelet resistance to antithrombotics.

Authors:  Antonio J López Farré; Juan Tamargo; Petra J Mateos-Cáceres; Luís Azcona; Carlos Macaya
Journal:  Pharm Res       Date:  2010-07-14       Impact factor: 4.200

2.  Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables.

Authors:  Gergely Feher; Katalin Koltai; Elod Papp; Balint Alkonyi; Alexander Solyom; Peter Kenyeres; Gabor Kesmarky; Laszlo Czopf; Kalman Toth
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 3.  New antithrombotic agents--insights from clinical trials.

Authors:  Jeremy S Paikin; John W Eikelboom; John A Cairns; Jack Hirsh
Journal:  Nat Rev Cardiol       Date:  2010-06-29       Impact factor: 32.419

Review 4.  Aspirin and antiplatelet agent resistance: implications for prevention of secondary stroke.

Authors:  David M Greer
Journal:  CNS Drugs       Date:  2010-12       Impact factor: 5.749

5.  Aspirin resistance in patients with acute ischemic stroke.

Authors:  Serkan Ozben; Beste Ozben; Azra Meryem Tanrikulu; Feriha Ozer; Tomris Ozben
Journal:  J Neurol       Date:  2011-04-21       Impact factor: 4.849

6.  Comparison of Different Laboratory Tests to Identify "Aspirin Resistance" and Risk of Vascular Events among Ischaemic Stroke Patients: A Double-Blind Study.

Authors:  Narayanaswamy Venketasubramanian; Sherwin Joy Agustin; Jorge L Padilla; Maricar P Yumul; Christina Sum; Sze Haur Lee; Kuperan Ponnudurai; Robert N Gan
Journal:  J Cardiovasc Dev Dis       Date:  2022-05-12

7.  Assessment of aspirin resistance varies on a temporal basis in patients with ischaemic heart disease.

Authors:  A R Muir; M F McMullin; C Patterson; P P McKeown
Journal:  Heart       Date:  2008-08-12       Impact factor: 5.994

Review 8.  Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review.

Authors:  Adel Alhazzani; Poongothai Venkatachalapathy; Sruthi Padhilahouse; Mohan Sellappan; Murali Munisamy; Mangaiyarkarasi Sekaran; Amit Kumar
Journal:  Front Neurol       Date:  2021-06-10       Impact factor: 4.003

9.  Aspirin treatment failure: is this a real phenomenon? A review of the aetiology and how to treat it.

Authors:  F Shahid; C A A Chahal; M J Akhtar
Journal:  JRSM Short Rep       Date:  2013-03-27

10.  Aspirin resistance and ischemic heart disease on Iranian experience.

Authors:  Masoumeh Sadeghi; Afsoon Emami; Naghmeh Ziyaei; Majid Yaran; Allahyar Golabchi; Azam Sadeghi
Journal:  Adv Biomed Res       Date:  2012-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.